Lefang Jiang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Timing-specific efficacy of antiviral baloxavir and anti-inflammatory oclacitinib monotherapies, and the benefits of their combination in treating influenza in mice.
Journal: Frontiers in microbiology
Published: November 06, 2025
Targeting the 5-HT7 receptor to block influenza virus entry: mechanistic insights and therapeutic potential of SB269970 HCl.
Journal: Frontiers in microbiology
Published: October 14, 2025
Screening of neurotransmitter receptor modulators reveals novel inhibitors of influenza virus replication.
Journal: Frontiers in cellular and infection microbiology
Published: January 17, 2025
Screening and identification of host signaling pathways for alleviating influenza-induced production of pro-inflammatory cytokines, IP-10, IL-8, and MCP-1, using a U937 cell-based influenza model.
Journal: Frontiers in microbiology
Published: November 26, 2024
LDC000067, a CDK9 inhibitor, unveils promising results in suppressing influenza virus infections in vitro and in vivo.
Journal: Antimicrobial agents and chemotherapy
Published: November 20, 2024
A panel of janus kinase inhibitors identified with anti-inflammatory effects protect mice from lethal influenza virus infection.
Journal: Antimicrobial agents and chemotherapy
Published: March 12, 2024
Identification of Inhibitors and Drug Targets for Human Adenovirus Infections.
Journal: Viruses
Published: April 11, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026